Key result
Electroconvulsive therapy is safe for patients with cardiac implantable electronic devices, with 75% of patients having uneventful sessions and no serious adverse effects requiring cessation.
Why the study?
The study aimed to report a case and systematically review published cases documenting the use of electroconvulsive therapy in patients with cardiac implantable electronic devices for treating major psychiatric disorders.
Is electroconvulsive therapy safe and efficacious in patients with cardiac implantable electronic devices?
Systematic Review (n=76)
Is electroconvulsive therapy safe and efficacious in patients with cardiac implantable electronic devices?
Answers are grounded in this paper and cite their sources.
Electroconvulsive therapy appears safe and efficacious for major psychiatric disorders in patients with cardiac implantable electronic devices, without serious adverse effects requiring treatment cessation.
OBJECTIVE: The aims of the study were to report the case of a 54-year-old man with recurrent depressive disorder with multiple medical comorbidities having a dual-chamber pacemaker, treated successfully with 11 sessions of electroconvulsive therapy, and to conduct a systematic review of published cases documenting the use of electroconvulsive therapy (ECT) in patients with cardiac implantable electronic devices (CIEDs) for treating major psychiatric disorders. METHODS: We searched electronic databases (MEDLINE, PubMed, Google Scholar, Embase, Cochrane Library, PsycINFO, and Crossref) and included studies reporting on the use of electroconvulsive therapy in patients with CIEDs. RESULTS: Thirty-five publications across 53 years (1967-2021) reported on 76 patients (including current report) who received a pooled total of 979 modified ECT sessions. The most common adverse events were premature ventricular contraction and hypertension. There have been no reports of serious adverse effects that necessitated the cessation of ECT. CONCLUSIONS: Electroconvulsive therapy is a safe and efficacious treatment for major psychiatric disorders, and the presence of CIEDs should not delay or deter the use of ECT in these patients.
No takes yet. Share an insight, caveat, or question.
Vaidyanathan et al. (2023) conducted a systematic review in Major psychiatric disorders with cardiac implantable electronic devices (n=76). Electroconvulsive therapy was evaluated on Adverse events immediately after ECT administration. Electroconvulsive therapy is safe for patients with cardiac implantable electronic devices, with 75% of patients having uneventful sessions and no serious adverse effects requiring cessation.
Synapse has enriched 10 related papers. Consider them for comparative context: